206 related articles for article (PubMed ID: 7740418)
1. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension.
Burns RC; Wu Y; Sitzmann JV
Surgery; 1995 May; 117(5):488-93. PubMed ID: 7740418
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
5. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
8. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
Geerts AM; Vanheule E; Praet M; Van Vlierberghe H; De Vos M; Colle I
Int J Exp Pathol; 2008 Aug; 89(4):251-63. PubMed ID: 18715470
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
11. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
Wong J; Zhang Y; Lee SS
J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
[TBL] [Abstract][Full Text] [Related]
14. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
15. Partial portal vein ligation plus thioacetamide: a method to obtain a new model of cirrhosis and chronic portal hypertension in the rat.
Méndez-López M; Méndez M; Sánchez-Patán F; Casado I; Aller MA; López L; Corcuera MT; Alonso MJ; Nava MP; Arias J; Arias JL
J Gastrointest Surg; 2007 Feb; 11(2):187-94. PubMed ID: 17390171
[TBL] [Abstract][Full Text] [Related]
16. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
[TBL] [Abstract][Full Text] [Related]
17. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
[TBL] [Abstract][Full Text] [Related]
18. Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats.
Song D; Sharkey KA; Breitman DR; Zhang Y; Lee SS
Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G420-30. PubMed ID: 11171624
[TBL] [Abstract][Full Text] [Related]
19. Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents.
Van Steenkiste C; Trachet B; Casteleyn C; van Loo D; Van Hoorebeke L; Segers P; Geerts A; Van Vlierberghe H; Colle I
Lab Invest; 2010 Nov; 90(11):1558-72. PubMed ID: 20714322
[TBL] [Abstract][Full Text] [Related]
20. Effects of Nuclear Factor-E2-related factor 2/Heme Oxygenase 1 on splanchnic hemodynamics in experimental cirrhosis with portal hypertension.
Qin J; He Y; Duan M; Luo M
Microvasc Res; 2017 May; 111():12-19. PubMed ID: 28025064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]